Hypervascularized Uterine Retentions Clinical Trial
Official title:
Diagnosis and Management of Enhanced Myometrial Vascularity Associated With Retained Products of Conception: a Retrospectif Moncentric Study
Background:
Hypervascularized products of conception remain a topic debated in terms of definitions
(ultrasound criteria, need complement by angio MRI) and management. The different uterine
vascular lesions are often confused. This is a recurrent problem and care are heterogeneous.
The aim of the study is to evaluate the management of these entities in CHU of Montpellier
and determine more homogeneous care. The investigators further aimed to evaluate clinical
presentation, ultrasound criteria, complications and the gynaecological and obstetrical
outcomes of patients •Methods: This study will be conducted in compliance of ethic comitee.
The investigators will collect data from 64 individuals, aged 18 to 50, suffering from
uterine vascular lesions associated or not with products of conception between 2013 and 2019.
Caracterisitics of the population, ultrasound and angio MRI data will be collected.
Management wll be described as expectative, surgery or embolization of uterine arteries and
the success or not will be noted. The investigators will question patients on their
gynaecologic and obstetrical outcomes by telephone.
•Discussion: The investigators aim to define and characterize the different lesions,
establish ultrasound criteria that would guide treatments. Describe the current treatments
and compare them in terms of efficiency and safety in order to establish a homogeneous
treatment protocol in our center
- data are collected by computer software and patient phone calls
- ultrasounds criteria are reviewed by two clinicians
- statistical analysis is realized by a independent clinician
- the consent and agreement of the ethics committee has been sought
;